Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPARγ partial agonists.
Peroxisome proliferator-activated receptor γ (PPARγ) is a well-known target for thiazolidinedione antidiabetic drugs. In this paper, we present the synthesis and biological evaluation of a series of dihydropyrano[2,3-c]pyrazole derivatives as a novel family of PPARγ partial agonists. Two analogues w...
Main Authors: | Katrine Qvortrup, Jakob F Jensen, Mikael S Sørensen, Irene Kouskoumvekaki, Rasmus K Petersen, Olivier Taboureau, Karsten Kristiansen, Thomas E Nielsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5330453?pdf=render |
Similar Items
-
Efficient synthesis of novel bis(dihydropyrano[2,3c]pyrazoles), bis(4H-chromenes) and bis(dihydropyrano[3,2-c]chromenes) with amide functionality
by: Amna M. Abdella, et al.
Published: (2019-12-01) -
Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.
by: Vinicius G Maltarollo, et al.
Published: (2015-01-01) -
PPARγ Agonists: Blood Pressure and Edema
by: Bonnie L. Blazer-Yost
Published: (2010-01-01) -
PPARγ Agonists: Emergent Therapy in Endometriosis
by: Alexandre Vallée, et al.
Published: (2021-06-01) -
Ring-closing metathesis as a key step to construct 2,6-dihydropyrano[2,3-c]pyrazole ring system
by: Aurimas Bieliauskas, et al.
Published: (2018-07-01)